M., Vicent-Gil
M., Serra-Blasco http://orcid.org/0000-0001-5793-9906
G., Navarra-Ventura
J., Trujols
V., Balanzá-Martínez
MJ., Portella
N., Cardoner
Funding for this research was provided by:
Lundbeckfonden
Article History
Received: 25 March 2022
Accepted: 29 August 2022
First Online: 9 September 2022
Declarations
:
: Dr. Maria J Portella was funded until 2020 by the Ministerio de Ciencia e Innovación of the Spanish Government and by the Instituto de Salud Carlos III through a ‘Miguel Servet-II’ research contract (CPII16-0020), National Research Plan (Plan Estatal de I + D + I 2016-2019), co-financed by the ERDF and by CERCA Programme/Generalitat de Catalunya; she received funding from the Health Research and Innovation Strategic Plan (PERIS) SLT006/17/00177, and honoraria as CME speaker from Pfizer and Lundbeck within the last 3 years. Dr. Narcís Cardoner declares that he has received funding from the Universitat Autònoma de Barcelona, from the Spanish Ministry of Science and Innovation, Instituto Carlos III and from Health Research and Innovation Strategic Plan (PERIS) 2016–2020. He has also received honoraria as consultant, advisor or CME speaker from Janssen, Lundbeck, Pfizer, Exeltis and MSD within the last 3 years. The rest of authors have nothing to disclose.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
: All participants provided written informed consent.